MCHPP Work in process decreased by 7.9% to $699.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.0%, from $874.40M to $699.90M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 20.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $410.30M | $421.70M | $429.90M | $482.80M | $551.80M | $619.20M | $679.40M | $809.80M | $854.70M | $859.60M | $799.60M | $797.50M | $843.90M | $880.10M | $874.40M | $857.60M | $793.20M | $760.20M | $699.90M |
| QoQ Change | — | +2.8% | +1.9% | +12.3% | +14.3% | +12.2% | +9.7% | +19.2% | +5.5% | +0.6% | -7.0% | -0.3% | +5.8% | +4.3% | -0.6% | -1.9% | -7.5% | -4.2% | -7.9% |
| YoY Change | — | — | — | — | +34.5% | +46.8% | +58.0% | +67.7% | +54.9% | +38.8% | +17.7% | -1.5% | -1.3% | +2.4% | +9.4% | +7.5% | -6.0% | -13.6% | -20.0% |
| % of Inventories | 60.0% | 59.1% | 56.0% | 56.5% | 60.5% | 60.1% | 58.3% | 61.1% | 64.0% | 64.6% | 61.0% | 60.6% | 64.5% | 65.7% | 64.5% | 66.3% | 67.8% | 69.4% | 66.2% |
| Share Change | — | -0.9pp | -3.1pp | +0.5pp | +4.0pp | -0.4pp | -1.8pp | +2.8pp | +2.8pp | +0.6pp | -3.6pp | -0.4pp | +3.9pp | +1.2pp | -1.2pp | +1.8pp | +1.5pp | +1.6pp | -3.2pp |